Concerns About Gabapentinoids in Psychiatric Practice - PubMed
4 days ago
- #Gabapentinoids
- #Psychiatric Practice
- #FDA
- Gabapentinoids are used to reduce central nervous system hyperexcitability, similar to benzodiazepines.
- Unlike benzodiazepines, gabapentinoids are not FDA-approved for treating psychiatric disorders.
- The article discusses indications, concerns, prescribing trends, and clinical guidance for gabapentinoids.
- No potential conflicts of interest were disclosed by the author.